- Home
- ALEC vs EVN Comparison
ALEC vs EVN Comparison
Compare ALEC & EVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALEC
- EVN
- Stock Information
- Founded
- ALEC 2013
- EVN 1998
- Country
- ALEC United States
- EVN United States
- Employees
- ALEC N/A
- EVN N/A
- Industry
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- EVN Investment Bankers/Brokers/Service
- Sector
- ALEC Health Care
- EVN Finance
- Exchange
- ALEC Nasdaq
- EVN Nasdaq
- Market Cap
- ALEC 454.5M
- EVN 441.5M
- IPO Year
- ALEC 2019
- EVN N/A
- Fundamental
- Price
- ALEC $3.76
- EVN $10.38
- Analyst Decision
- ALEC Strong Buy
- EVN
- Analyst Count
- ALEC 5
- EVN 0
- Target Price
- ALEC $20.67
- EVN N/A
- AVG Volume (30 Days)
- ALEC 749.0K
- EVN 101.2K
- Earning Date
- ALEC 11-06-2024
- EVN 01-01-0001
- Dividend Yield
- ALEC N/A
- EVN 4.78%
- EPS Growth
- ALEC N/A
- EVN N/A
- EPS
- ALEC N/A
- EVN 0.34
- Revenue
- ALEC $61,508,000.00
- EVN N/A
- Revenue This Year
- ALEC N/A
- EVN N/A
- Revenue Next Year
- ALEC $118.87
- EVN N/A
- P/E Ratio
- ALEC N/A
- EVN $29.94
- Revenue Growth
- ALEC N/A
- EVN N/A
- 52 Week Low
- ALEC $3.49
- EVN $8.64
- 52 Week High
- ALEC $8.90
- EVN $10.45
- Technical
- Relative Strength Index (RSI)
- ALEC 35.09
- EVN 37.22
- Support Level
- ALEC $3.57
- EVN $10.40
- Resistance Level
- ALEC $6.14
- EVN $10.60
- Average True Range (ATR)
- ALEC 0.48
- EVN 0.10
- MACD
- ALEC -0.20
- EVN 0.01
- Stochastic Oscillator
- ALEC 10.19
- EVN 21.43
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.
About EVN Eaton Vance Municipal Income Trust
Eaton Vance Municipal Income Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax. The trust's portfolio of investments majorly consists of debt instruments of governments, municipal organizations the interest on which is exempt from regular federal income tax and has also some exposure to corporate bonds and other instruments.